Globus Medical (GMED) Cost of Revenue (2011 - 2026)

Globus Medical (GMED) has 16 years of Cost of Revenue data on file, last reported at $234.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 19.79% year-over-year to $234.1 million; the trailing twelve-month figure through Mar 2026 stood at $996.5 million (up 0.72% YoY), and the FY2025 full-year result was $957.8 million, down 7.5% from the prior year.
• Cost of Revenue for Q1 2026 stood at $234.1 million, down from $261.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $270.5 million in Q3 2024 and bottomed at $59.2 million in Q1 2022.
• The 5-year median for Cost of Revenue is $234.1 million (2026), against an average of $178.8 million.
• The widest annual swing landed in 2023, when Cost of Revenue soared 276.09%; it then declined 19.09% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $70.6 million in 2022, then jumped by 276.09% to $265.5 million in 2023, then slipped by 0.77% to $263.4 million in 2024, then fell by 0.88% to $261.1 million in 2025, then retreated by 10.36% to $234.1 million in 2026.
• The last three Cost of Revenue figures came in at $234.1 million (Q1 2026), $261.1 million (Q4 2025), and $252.5 million (Q3 2025), per Business Quant data.

Peer Comparison